<--- Back to Details
First PageDocument Content
Cytokines / Antivirals / Ebola / Animal virology / Biological weapons / Interferon / Ebola virus disease / Ebola virus
Date: 2014-10-03 04:51:33
Cytokines
Antivirals
Ebola
Animal virology
Biological weapons
Interferon
Ebola virus disease
Ebola virus

MAJOR ARTICLE Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever Lauren M. Smith,1,a Lisa E. Hensley,2,b Thomas W. Geisbert,2,c Joshua Johnson,2 Andrea Stossel,2 Anna

Add to Reading List

Source URL: www.scsml.rssi.ru

Download Document from Source Website

File Size: 4,77 MB

Share Document on Facebook

Similar Documents

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C   New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

IMPORTANT PLEASE READ  PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part

IMPORTANT PLEASE READ PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part "Product Monograph"

DocID: 1uNBi - View Document

Evaluation of Interferon-gamma-Producing T Cells

Evaluation of Interferon-gamma-Producing T Cells

DocID: 1uFKZ - View Document

PRODUCT MONOGRAPH  INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vial

PRODUCT MONOGRAPH INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vial

DocID: 1umTG - View Document

  Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.:  µg)

  Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.: µg)

DocID: 1u1rK - View Document